cas 2034357-75-8|| where to buy 2-{1-[4-(trifluoromethoxy)benzenesulfonyl]azetidin-3-yl}-1,2,3,4-tetrahydroisoquinoline

Nombre del producto:2-{1-[4-(trifluoromethoxy)benzenesulfonyl]azetidin-3-yl}-1,2,3,4-tetrahydroisoquinoline

IUPAC Name:2-{1-[4-(trifluoromethoxy)benzenesulfonyl]azetidin-3-yl}-1,2,3,4-tetrahydroisoquinoline

: CAS：2034357-75-8; Fórmula molecular：C19H19F3N2O3S; Pureza：95%+

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2034357-75-8 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :2034357-75-8; Fórmula molecular:C19H19F3N2O3S; Punto de fusión:-; Código de sonrisas:FC(F)(F)OC1=CC=C(C=C1)S(=O)(=O)N1CC(C1)N1CCC2=C(C1)C=CC=C2; Densidad:

: Número de catálogo:CM844360; Peso molecular:412.43; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Azetidines; Azetidines are an important class of saturated four-membered nitrogen-containing heterocyclic compounds. The research hotspots related to this structure mainly focus on two aspects: one is the research of pharmaceutical chemistry; the other is related to chiral azetidines, using rigid azetidine compounds as chiral ligands for asymmetric catalytic reactions. Many nitrogen-containing heterocycles play important roles in drug structures, and in many cases small structural changes can improve ligand selectivity and pharmacokinetic properties.; Where to buy Azetidines; Where to buy ADC-Cytotoxins? Chemenu Provide Azetidines with high quality and competitive price. Contact us Now.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.